Inflammatory Markers and Incident Mobility Limitation in the Elderly

Inflammatory Markers and Incident Mobility Limitation in the Elderly Objectives: To examine the relationship between indicators of inflammation and the incidence of mobility limitation in older persons. Design: Prospective cohort study: the Health, Aging and Body Composition Study. Setting: Pittsburgh, Pennsylvania, and Memphis, Tennessee. Participants: A total of 2,979 men and women, aged 70 to 79, without mobility limitation at baseline. Measurements: Serum levels of interleukin (IL)‐6, tumor necrosis factor alpha (TNFα), and C‐reactive protein (CRP) and soluble cytokine receptors (IL‐2sR, IL‐6sR, TNFsR1, TNFsR2) were measured. Mobility limitation was assessed and defined as reporting difficulty or inability to walk one‐quarter of a mile or to climb 10 steps during two consecutive semiannual assessments over 30 months. Results: Of the 2,979 participants, 30.1% developed incident mobility limitation. After adjustment for confounders (demographics, prevalent conditions at baseline, body composition), the relative risk (RR) of incident mobility limitation per standard deviation (SD) increase was 1.19 (95% confidence interval (CI)=1.10–1.28) for IL‐6, 1.20 (95% CI=1.12–1.29) for TNFα, and 1.40 (95% CI=1.18–1.68) for CRP. The association between inflammation and incident mobility limitation was especially strong for the onset of more severe mobility limitation and when the levels of multiple inflammatory markers were high. When persons with baseline or incident cardiovascular disease events or persons who were hospitalized during study follow‐up were excluded, findings remained similar. In a subset (n=499), high levels of the soluble receptors IL2sR and TNFsR1 (per SD increase: RR=1.23 (95% CI=1.04–1.46) and RR=1.28 (95% CI=1.04–1.57), respectively) were also associated with incident mobility limitation. Conclusion: Findings suggest that inflammation is prognostic for incident mobility limitation over 30 months, independent of cardiovascular disease events and incident severe illness. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of American Geriatrics Society Wiley

Loading next page...
 
/lp/wiley/inflammatory-markers-and-incident-mobility-limitation-in-the-elderly-WSAifbSMtB
Publisher
Wiley
Copyright
Copyright © 2004 Wiley Subscription Services, Inc., A Wiley Company
ISSN
0002-8614
eISSN
1532-5415
D.O.I.
10.1111/j.1532-5415.2004.52308.x
Publisher site
See Article on Publisher Site

Abstract

Objectives: To examine the relationship between indicators of inflammation and the incidence of mobility limitation in older persons. Design: Prospective cohort study: the Health, Aging and Body Composition Study. Setting: Pittsburgh, Pennsylvania, and Memphis, Tennessee. Participants: A total of 2,979 men and women, aged 70 to 79, without mobility limitation at baseline. Measurements: Serum levels of interleukin (IL)‐6, tumor necrosis factor alpha (TNFα), and C‐reactive protein (CRP) and soluble cytokine receptors (IL‐2sR, IL‐6sR, TNFsR1, TNFsR2) were measured. Mobility limitation was assessed and defined as reporting difficulty or inability to walk one‐quarter of a mile or to climb 10 steps during two consecutive semiannual assessments over 30 months. Results: Of the 2,979 participants, 30.1% developed incident mobility limitation. After adjustment for confounders (demographics, prevalent conditions at baseline, body composition), the relative risk (RR) of incident mobility limitation per standard deviation (SD) increase was 1.19 (95% confidence interval (CI)=1.10–1.28) for IL‐6, 1.20 (95% CI=1.12–1.29) for TNFα, and 1.40 (95% CI=1.18–1.68) for CRP. The association between inflammation and incident mobility limitation was especially strong for the onset of more severe mobility limitation and when the levels of multiple inflammatory markers were high. When persons with baseline or incident cardiovascular disease events or persons who were hospitalized during study follow‐up were excluded, findings remained similar. In a subset (n=499), high levels of the soluble receptors IL2sR and TNFsR1 (per SD increase: RR=1.23 (95% CI=1.04–1.46) and RR=1.28 (95% CI=1.04–1.57), respectively) were also associated with incident mobility limitation. Conclusion: Findings suggest that inflammation is prognostic for incident mobility limitation over 30 months, independent of cardiovascular disease events and incident severe illness.

Journal

Journal of American Geriatrics SocietyWiley

Published: Jul 1, 2004

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off